Literature DB >> 10491361

Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosus.

N Pourmand1, M Wahren-Herlenius, I Gunnarsson, E Svenungsson, B Löfström, Y Ioannou, D A Isenberg, C G Magnusson.   

Abstract

OBJECTIVE: To investigate the occurrence of IgA autoantibodies to Ro 52 kDa, Ro 60 kDa and La antigen in serum of patients with primary Sjögren's syndrome (pSS) and systemic lupus erythematosus (SLE).
METHODS: Recombinant Ro 52 kDa, Ro 60 kDa and La antigens were used to analyse autoantibodies in serum from 25 patients with pSS, 30 patients with SLE and 20 controls using a semiquantitative immunoblotting approach.
RESULTS: Among the patients with pSS, 21 (84%) had detectable IgA autoantibodies to Ro 52 kDa, 13 (52%) to Ro 60 kDa and 20 (80%) to La antigen. The corresponding results for the patients with SLE were 22 (73%), 14 (47%) and 20 (67%), respectively. No IgA autoantibodies against the three antigens were detected in 20 normal controls. A comparison of several clinical features with the titres of IgA antibodies to Ro 52 kDa, Ro 60 kDa and La, revealed a significant relation between IgA anti-Ro 52 and IgA anti-La to sicca (p< 0.05). Semiquantitative data suggest that IgG is the dominating antibody to the three antigens followed by IgM > IgA in both SLE and pSS patients. Specificity studies of IgA autoantibodies with different subfragments of Ro 52 kDa and Ro 60 kDa antigens showed that IgA antibodies did not differ from IgG and IgM in their recognition pattern.
CONCLUSION: These results suggest that besides IgM and IgG, IgA autoantibodies are also detected at high frequency in patients with pSS and SLE. Further studies are necessary to evaluate the contribution of these IgA autoantibodies to inflammation as well as their diagnostic value.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10491361      PMCID: PMC1752767          DOI: 10.1136/ard.58.10.623

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  46 in total

1.  Ro/SS-A- and La/SS-B-reactive B lymphocytes in peripheral blood of patients with Sjögren's syndrome.

Authors:  A Halse; M Wahren-Herlenius; R Jonsson
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 2.  Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response.

Authors:  J Mestecky; J R McGhee
Journal:  Adv Immunol       Date:  1987       Impact factor: 3.543

3.  A physicochemical study of protein G, a molecule with unique immunoglobulin G-binding properties.

Authors:  B Akerström; L Björck
Journal:  J Biol Chem       Date:  1986-08-05       Impact factor: 5.157

4.  Autoantibodies in the sicca syndrome (primary Sjögren's syndrome).

Authors:  K B Elkon; A E Gharavi; G R Hughes; H M Moutsoupoulos
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

5.  Purified lupus antigen La recognizes an oligouridylate stretch common to the 3' termini of RNA polymerase III transcripts.

Authors:  J E Stefano
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

6.  Nucleotide sequence of 4.5S RNA (C8 or hY5) from HeLa cells.

Authors:  N Kato; H Hoshino; F Harada
Journal:  Biochem Biophys Res Commun       Date:  1982-09-16       Impact factor: 3.575

7.  Serum IgA1 and IgA2 in normal adults and patients with systemic lupus erythematosus and hepatic disease.

Authors:  M E Conley; W J Koopman
Journal:  Clin Immunol Immunopathol       Date:  1983-03

8.  IgA-containing circulating immune complexes in patients with igA nephropathy.

Authors:  R P Hall; I Stachura; J Cason; T L Whiteside; T J Lawley
Journal:  Am J Med       Date:  1983-01       Impact factor: 4.965

9.  Ro small cytoplasmic ribonucleoproteins are a subclass of La ribonucleoproteins: further characterization of the Ro and La small ribonucleoproteins from uninfected mammalian cells.

Authors:  J P Hendrick; S L Wolin; J Rinke; M R Lerner; J A Steitz
Journal:  Mol Cell Biol       Date:  1981-12       Impact factor: 4.272

10.  The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs.

Authors:  S L Wolin; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

View more
  13 in total

1.  Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases.

Authors:  H Chikazawa; K Nishiya; A Matsumori; K Hashimoto
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

2.  Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.

Authors:  Cuong Q Nguyen; Hyuna Kim; Janet G Cornelius; Ammon B Peck
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

3.  Functional expression of IgA receptor FcalphaRI on human platelets.

Authors:  Kun Qian; Fenglong Xie; Andrew W Gibson; Jeffrey C Edberg; Robert P Kimberly; Jianming Wu
Journal:  J Leukoc Biol       Date:  2008-09-10       Impact factor: 4.962

4.  Irgm1 coordinately regulates autoimmunity and host defense at select mucosal surfaces.

Authors:  Kathleen M Azzam; Jennifer H Madenspacher; Derek W Cain; Lihua Lai; Kymberly M Gowdy; Prashant Rai; Kyathanahalli Janardhan; Natasha Clayton; Willie Cunningham; Heather Jensen; Preeyam S Patel; John F Kearney; Gregory A Taylor; Michael B Fessler
Journal:  JCI Insight       Date:  2017-08-17

5.  IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren's syndrome-like disease of the nonobese diabetic mouse.

Authors:  Cuong Q Nguyen; Jue-hua Gao; Hyuna Kim; Daniel R Saban; Janet G Cornelius; Ammon B Peck
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

6.  Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.

Authors:  E Toker; S Yavuz; H Direskeneli
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

7.  Salivary glands of primary Sjögren's syndrome patients express factors vital for plasma cell survival.

Authors:  Ewa A Szyszko; Karl A Brokstad; Gunnvor Oijordsbakken; Malin V Jonsson; Roland Jonsson; Kathrine Skarstein
Journal:  Arthritis Res Ther       Date:  2011-01-07       Impact factor: 5.156

8.  Specificity of anti-SSB as a diagnostic marker for the classification of systemic lupus erythematosus.

Authors:  Li Rao; Guiyan Liu; Chunfen Li; Yajuan Li; Zhiguo Wang; Zijiao Zhou; Shengquan Tong; Xianming Wu
Journal:  Exp Ther Med       Date:  2013-04-08       Impact factor: 2.447

9.  Identification of possible candidate genes regulating Sjögren's syndrome-associated autoimmunity: a potential role for TNFSF4 in autoimmune exocrinopathy.

Authors:  Cuong Q Nguyen; Janet G Cornelius; Lauren Cooper; Jonathan Neff; Joann Tao; Byung Ha Lee; Ammon B Peck
Journal:  Arthritis Res Ther       Date:  2008-11-25       Impact factor: 5.156

10.  The Interferon-Signature of Sjögren's Syndrome: How Unique Biomarkers Can Identify Underlying Inflammatory and Immunopathological Mechanisms of Specific Diseases.

Authors:  Cuong Quoc Nguyen; Ammon Broughton Peck
Journal:  Front Immunol       Date:  2013-07-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.